Hem

Press release from Companies

Publicerat: 2022-11-03 01:44:27

Eevia Health Plc: Eevia Health Plc launches a new dietary supplement ingredient, Feno-Cerasus™, for cognitive health at a key industry trade show, Supply Side West in Las Vegas, US

Eevia Health has developed a new plant extract with product benefits for cognitive health and improved sleep. The new product, Feno-Cerasus™, is launched today at a major trade show in Las Vegas, US, the Supply Side West. The new ingredient is a standardized anthocyanin extract from tart cherry (Prunus Cerasus). Eevia Health focuses on the cognitive effects of the new products, including sleep quality and quantity, memory, as well as stress, and cortisol levels.

The main health benefit Eevia Health is promoting is improved cognitive function. Tart cherry has one clinical study with 37 subjects showing a positive effect on cognitive performance. Another four clinical studies with 63 subjects documented positive outcomes in sleep quality parameters. From PubMed 10/2022 one can also observe that 39 clinical studies have been published in peer-reviewed journals. Tart Cherries have been studied for Muscle recovery (15 studies, 280 subjects), Metabolic health (8 studies, 180 subjects), Cardiovascular health (5 studies, 150 subjects), Antioxidant properties in clinical studies (2 studies, 59 subjects), and positive results also in pain (2 studies, 108 subjects). Eevia Health’s recent strategic focus on cellular recycling also is supported as the tart cherry has preclinical evidence of autophagy induction via AMPK signal pathway and anti-inflammatory properties via Sirtuin6 activation of cyanidin, which has been confirmed in in-vitro studies.

 

Eevia’s manufacturing also ensures sustainability with the lowest Product Carbon Footprint (PCF) known in the industry. The Feno-Cerasus is organically certified under NOP, Euroleaf, Ecocert, JAS, and other standards. It is standardized to 10% Anthocyanins including anthocyanins with cyanidin-3-glucoside and cyanidin-3-rutinoside. Eevia Health’s superior extraction and purification technology provide for a superior bioactive and nutritional profile. Feno-Cerasus™ is high on other polyphenols with a natural spectrum of polyphenolic compounds. It is a non-GMO, gluten-free, vegan ingredient with an excellent taste profile, highly suitable for gummies and other applications. Feno-Cerasus™ Organic is a superior standardized product with superior bioactive content available benefits 

 

“We are pleased to offer a new anthocyanin extract for cognitive health. The maintenance of cognitive health is a growing area for consumers. Eevia Health already has customer interest. The product will have perhaps the highest concentration of anthocyanins in the industry, while providing also a whole spectrum of other health-beneficial polyphenols as well.” says Petri Lackman, CTO of Eevia Health.

 

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc  

Email: stein.ulve@eeviahealth.com  
Telephone: +358 400 22 5967                     

This information is such that Eevia Health Plc is required to make it public in accordance with the EU's Market Abuse Regulation (MAR). The information was made public by the Company's contact person above on November 3rd, 2022, at 1:40 CEST.    

  

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth. 

 

Läs mer hos Cision
Läs mer om Eevia Health Plc

Prenumeration